LAM Therapeutics Inc. Report issue

For profit Phase 1
Founded: Guilford CT United States (2013)

Organization Overview

First Clinical Trial
2015
NCT02594384
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

LAM Therapeutics | Lam Therapeutics Inc.